The future of catalysis in immunotherapy looks promising. Advances in enzyme engineering and nanotechnology are paving the way for more effective and targeted therapies. For example, nanoparticle-based catalysts can be designed to activate immune cells precisely at the site of a tumor, enhancing the efficacy of cancer treatments.
